Chrisna Durandt

973 total citations
35 papers, 710 citations indexed

About

Chrisna Durandt is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Chrisna Durandt has authored 35 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Chrisna Durandt's work include Mesenchymal stem cell research (12 papers), Cancer Cells and Metastasis (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Chrisna Durandt is often cited by papers focused on Mesenchymal stem cell research (12 papers), Cancer Cells and Metastasis (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Chrisna Durandt collaborates with scholars based in South Africa, United Kingdom and France. Chrisna Durandt's co-authors include Michael S. Pepper, Melvin Ambele, Carla Dessels, Ronald Anderson, Charles Feldman, Timothy J. Mitchell, Gregory R. Tintinger, Marnie Potgieter, Annette J. Theron and Riana Cockeran and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and The Journal of Infectious Diseases.

In The Last Decade

Chrisna Durandt

35 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chrisna Durandt South Africa 15 191 173 127 115 92 35 710
Yun Guo China 13 186 1.0× 144 0.8× 56 0.4× 74 0.6× 97 1.1× 38 603
Peter Marschang Austria 19 234 1.2× 140 0.8× 123 1.0× 66 0.6× 341 3.7× 45 1.1k
Atsushi Satomura Japan 19 322 1.7× 131 0.8× 83 0.7× 35 0.3× 199 2.2× 69 919
Luisa Doneda Italy 21 343 1.8× 264 1.5× 60 0.5× 57 0.5× 95 1.0× 84 1.2k
Nilesh Morar United Kingdom 17 116 0.6× 181 1.0× 217 1.7× 49 0.4× 250 2.7× 28 1.1k
Wael N. Jarjour United States 18 439 2.3× 130 0.8× 74 0.6× 79 0.7× 380 4.1× 54 1.1k
Benoît Gilbert Switzerland 9 441 2.3× 122 0.7× 77 0.6× 47 0.4× 181 2.0× 26 1.1k
Liang Yu China 14 139 0.7× 217 1.3× 40 0.3× 110 1.0× 70 0.8× 33 701
Pascale Cornillet France 14 218 1.1× 106 0.6× 72 0.6× 90 0.8× 206 2.2× 22 838
Lu Jiang China 14 446 2.3× 228 1.3× 94 0.7× 44 0.4× 43 0.5× 45 814

Countries citing papers authored by Chrisna Durandt

Since Specialization
Citations

This map shows the geographic impact of Chrisna Durandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chrisna Durandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chrisna Durandt more than expected).

Fields of papers citing papers by Chrisna Durandt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chrisna Durandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chrisna Durandt. The network helps show where Chrisna Durandt may publish in the future.

Co-authorship network of co-authors of Chrisna Durandt

This figure shows the co-authorship network connecting the top 25 collaborators of Chrisna Durandt. A scholar is included among the top collaborators of Chrisna Durandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chrisna Durandt. Chrisna Durandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mellet, Juanita, et al.. (2024). Extensive immunophenotypic sub-population analysis of StemRegenin1 expanded haematopoietic stem/progenitor cells. Stem Cell Research & Therapy. 15(1). 317–317. 1 indexed citations
2.
Mellet, Juanita, et al.. (2023). Consequences of HIV infection in the bone marrow niche. Frontiers in Immunology. 14. 1163012–1163012. 9 indexed citations
3.
Mellet, Juanita, et al.. (2023). Haematopoietic stem-cell transplantation in an HIV endemic area: time to consider donors exposed to or living with HIV. The Lancet HIV. 10(11). e742–e749. 2 indexed citations
4.
Durandt, Chrisna, et al.. (2023). Effect of 2‐methoxyestradiol treatment on early‐ and late‐stage breast cancer progression in a mouse model. Cell Biochemistry and Function. 41(7). 898–911. 5 indexed citations
5.
Durandt, Chrisna, et al.. (2022). Determinants of Dental Pulp Stem Cell Heterogeneity. Journal of Endodontics. 48(10). 1232–1240. 10 indexed citations
6.
Damerell, Victoria, et al.. (2022). The c-Myc/TBX3 Axis Promotes Cellular Transformation of Sarcoma-Initiating Cells. Frontiers in Oncology. 11. 801691–801691. 9 indexed citations
7.
Durandt, Chrisna, et al.. (2021). An In Vitro and In Vivo Comparison of Osteogenic Differentiation of Human Mesenchymal Stromal/Stem Cells. Stem Cells International. 2021. 1–23. 46 indexed citations
8.
Mellet, Juanita, et al.. (2021). Single-Cell Transcriptome Analysis of Human Adipose-Derived Stromal Cells Identifies a Contractile Cell Subpopulation. Stem Cells International. 2021. 1–12. 5 indexed citations
9.
Durandt, Chrisna, et al.. (2020). The Role of Pref-1 during Adipogenic Differentiation: An Overview of Suggested Mechanisms. International Journal of Molecular Sciences. 21(11). 4104–4104. 35 indexed citations
10.
11.
Anderson, Ronald, Annette J. Theron, Chrisna Durandt, et al.. (2018). Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation in vitro. Frontiers in Pharmacology. 9. 1335–1335. 10 indexed citations
12.
Durandt, Chrisna, et al.. (2018). Side Population: Its Use in the Study of Cellular Heterogeneity and as a Potential Enrichment Tool for Rare Cell Populations. Stem Cells International. 2018. 1–7. 13 indexed citations
13.
Durandt, Chrisna, Annette J. Theron, Gregory R. Tintinger, et al.. (2017). Pneumolysin mediates heterotypic aggregation of neutrophils and platelets in vitro. Journal of Infection. 74(6). 599–608. 21 indexed citations
15.
Ambele, Melvin, Carla Dessels, Chrisna Durandt, & Michael S. Pepper. (2016). Genome-wide analysis of gene expression during adipogenesis in human adipose-derived stromal cells reveals novel patterns of gene expression during adipocyte differentiation. Stem Cell Research. 16(3). 725–734. 92 indexed citations
16.
Durandt, Chrisna, et al.. (2016). Pneumolysin Mediates Platelet Activation In Vitro. Lung. 194(4). 589–593. 32 indexed citations
17.
Stout, Tom A. E., et al.. (2015). Validation of merocyanine 540 staining as a technique for assessing capacitation-related membrane destabilization of fresh dog sperm. Theriogenology. 83(9). 1451–1460. 24 indexed citations
18.
Hochfeld, Warren E., Heidi Fickl, Chrisna Durandt, et al.. (2013). Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study. BMC Medical Genetics. 14(1). 20–20. 42 indexed citations
19.
Cockeran, Riana, Chrisna Durandt, Charles Feldman, Timothy J. Mitchell, & Ronald Anderson. (2002). Pneumolysin Activates the Synthesis and Release of Interleukin‐8 by Human Neutrophils In Vitro. The Journal of Infectious Diseases. 186(4). 562–565. 66 indexed citations
20.
Durandt, Chrisna, et al.. (1993). EVALUATION OF THE ANTINEOPLASTIC ACTIVITIES OF THE RIMINOPHENAZINE AGENTS CLOFAZIMINE AND B669 IN TUMOR-BEARING RATS AND MICE. International Journal of Oncology. 3(5). 1011–3. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026